


The Fund's sole aim is capital growth by investing principally in the equities of UK companies with high growth potential. Income considerations are ignored.
| Name | % Net Assets | 
|---|---|
| BP | 8.6% | 
| HSBC | 6.7% | 
| Royal Dutch Shell | 6.6% | 
| Vodafone Group | 4.4% | 
| BAT | 4.3% | 
| GlaxoSmithKline | 4.1% | 
| Tesco | 3.6% | 
| BG | 3.6% | 
| AstraZeneca | 3.0% | 
| Reckitt Benckiser | 2.8% | 
| Key | % Net Assets | 
|---|---|
| 8.6% | |
| 6.7% | |
| 6.6% | |
| 4.4% | |
| 73.7% | 
| Date | 14-Dec-2020 | 
|---|---|
| NAV | 14.65p | 
| Currency | GBP | 
| Change | 0.34p | 
| % | 2.37% | 
| YTD change | 14.65p | 
| YTD % | n/a | 
| Fund Inception | 17/12/1968 | 
|---|---|
| Fund Manager | Simon Murphy | 
| TER | 1.66 (30-Nov-2013) | 
| Minimum Investment | |
|---|---|
| Initial | n/a | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 4.00% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research